Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Pasternak

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Neuromuscular Disorders : NMD|June 27, 2024
Changes in abilities over the initial 12 months of nusinersen treatment for type II SMAGiorgia Coratti, Matthew Civitello, Annemarie Rohwer, et al.
Annals of Clinical and Translational Neurology|June 24, 2021
Nusinersen in pediatric and adult patients with type III spinal muscular atrophyMaria Carmela Pera, Giorgia Coratti, Francesca Bovis, et al.
Journal of Clinical Medicine|March 11, 2023
2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA ParticipantsGeorgia Stimpson, Danielle Ramsey, Amy Wolfe, et al.
European Journal of Neurology|April 24, 2024
Determining minimal clinically important differences in the Hammersmith Functional Motor Scale Expanded for untreated spinal muscular atrophy patients: An international studyGiorgia Coratti, Francesca Bovis, Maria Carmela Pera, et al.
Neuromuscular Disorders : NMD|September 19, 2024
Upper limb function changes over 12 months in untreated SMA II and III individuals: an item-level analysis using the Revised Upper Limb ModuleGiorgia Coratti, Matthew Civitello, Annemarie Rohwer, et al.
Muscle & Nerve|July 30, 2021
Different trajectories in upper limb and gross motor function in spinal muscular atrophyGiorgia Coratti, Maria Carmela Pera, Jacqueline Montes, et al.
European Journal of Neurology|June 27, 2025
Longitudinal Assessment of 4-Year HFMSE Changes in SMA II and III Patients Treated With NusinersenGiorgia Coratti, Francesca Bovis, Marika Pane, et al.
Journal of Neuromuscular Diseases|March 1, 2024
Disease Trajectories in the Revised Hammersmith Scale in a Cohort of Untreated Patients with Spinal Muscular Atrophy types 2 and 3Amy Wolfe, Georgia Stimpson, Danielle Ramsey, et al.
Neuromuscular Disorders : NMD|January 4, 2022
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changesGiorgia Coratti, Maria Carmela Pera, Jacqueline Montes, et al.
European Journal of Neurology|October 11, 2024
Long-term natural history in type II and III spinal muscular atrophy: a 4-year international study on the Hammersmith Functional Motor Scale ExpandedGiorgia Coratti, Francesca Bovis, Maria Carmela Pera, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Neuromuscular Disorders : NMD|June 27, 2024
Changes in abilities over the initial 12 months of nusinersen treatment for type II SMAGiorgia Coratti, Matthew Civitello, Annemarie Rohwer, et al.
Annals of Clinical and Translational Neurology|June 24, 2021
Nusinersen in pediatric and adult patients with type III spinal muscular atrophyMaria Carmela Pera, Giorgia Coratti, Francesca Bovis, et al.
Journal of Clinical Medicine|March 11, 2023
2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA ParticipantsGeorgia Stimpson, Danielle Ramsey, Amy Wolfe, et al.
European Journal of Neurology|April 24, 2024
Determining minimal clinically important differences in the Hammersmith Functional Motor Scale Expanded for untreated spinal muscular atrophy patients: An international studyGiorgia Coratti, Francesca Bovis, Maria Carmela Pera, et al.
Neuromuscular Disorders : NMD|September 19, 2024
Upper limb function changes over 12 months in untreated SMA II and III individuals: an item-level analysis using the Revised Upper Limb ModuleGiorgia Coratti, Matthew Civitello, Annemarie Rohwer, et al.
Muscle & Nerve|July 30, 2021
Different trajectories in upper limb and gross motor function in spinal muscular atrophyGiorgia Coratti, Maria Carmela Pera, Jacqueline Montes, et al.
European Journal of Neurology|June 27, 2025
Longitudinal Assessment of 4-Year HFMSE Changes in SMA II and III Patients Treated With NusinersenGiorgia Coratti, Francesca Bovis, Marika Pane, et al.
Journal of Neuromuscular Diseases|March 1, 2024
Disease Trajectories in the Revised Hammersmith Scale in a Cohort of Untreated Patients with Spinal Muscular Atrophy types 2 and 3Amy Wolfe, Georgia Stimpson, Danielle Ramsey, et al.
Neuromuscular Disorders : NMD|January 4, 2022
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changesGiorgia Coratti, Maria Carmela Pera, Jacqueline Montes, et al.
European Journal of Neurology|October 11, 2024
Long-term natural history in type II and III spinal muscular atrophy: a 4-year international study on the Hammersmith Functional Motor Scale ExpandedGiorgia Coratti, Francesca Bovis, Maria Carmela Pera, et al.
Pageof 6